Apricus Biosciences Announces Appointment of Dr. Kleanthis G. Xanthopoulos to Its Board of Directors

by Matthew Kennedy, Benzinga Staff Writer

November 21, 2011 9:51 AM | 11 seconds read | Make a Comment

Apricus Biosciences, Inc.

APRI

announced today that Kleanthis G. Xanthopoulos, Ph.D., President and Chief Executive Officer of Regulus Therapeutics Inc., has been appointed to the Company's Board of Directors, effective immediately.

Market News and Data brought to you by Benzinga APIs

Posted In: News Management

Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Apricus Biosciences Announces Appointment of Dr. Kleanthis G. Xanthopoulos to Its Board of Directors